AP NEWS

Psoriatic Arthritis Pipeline Review, H1 2018 - ResearchAndMarkets.com

June 5, 2018

DUBLIN--(BUSINESS WIRE)--Jun 5, 2018--The “Psoriatic Arthritis - Pipeline Review, H1 2018” report has been added to ResearchAndMarkets.com’s offering.

The pipeline guide provides a snapshot of the global therapeutic landscape of Psoriatic Arthritis (Musculoskeletal Disorders).

The pipeline guide reviews pipeline therapeutics for Psoriatic Arthritis (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Psoriatic Arthritis (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Psoriatic Arthritis (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Psoriatic Arthritis (Musculoskeletal Disorders).

Key Topics Covered

Introduction Psoriatic Arthritis - Overview Psoriatic Arthritis - Therapeutics Development Psoriatic Arthritis - Therapeutics Assessment Psoriatic Arthritis - Companies Involved in Therapeutics Development Psoriatic Arthritis - Drug Profiles Psoriatic Arthritis - Dormant Projects Psoriatic Arthritis - Discontinued Products Psoriatic Arthritis - Product Development Milestones Appendix

Companies Mentioned

3SBio Inc AbbVie Inc AbGenomics International Inc Aclaris Therapeutics Inc Adello Biologics LLC Alteogen Inc Amgen Inc Biocon Ltd Bionovis SA Coherus BioSciences Inc Eli Lilly and Co Fresenius SE & Co KGaA FYB202 GmbH

For more information about this report visit https://www.researchandmarkets.com/research/d9c525/psoriatic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180605006564/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Immune Disorders Drugs,Musculoskeletal Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/05/2018 02:43 PM/DISC: 06/05/2018 02:43 PM

http://www.businesswire.com/news/home/20180605006564/en

AP RADIO
Update hourly